Ballentine Partners, LLC United Therapeutics Corp Transaction History
Ballentine Partners, LLC
- $7.1 Billion
- Q3 2025
A detailed history of Ballentine Partners, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Ballentine Partners, LLC holds 498 shares of UTHR stock, worth $232,267. This represents 0.0% of its overall portfolio holdings.
Number of Shares
498Holding current value
$232,267% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding UTHR
# of Institutions
806Shares Held
41.4MCall Options Held
1.56MPut Options Held
2.87M-
Black Rock Inc. New York, NY5.47MShares$2.55 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.42MShares$2.06 Billion0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.17MShares$1.01 Billion1.29% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.02MShares$943 Million11.58% of portfolio
-
State Street Corp Boston, MA1.92MShares$897 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $21.2B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...